FARMINGDALE, N.Y., Sept. 28 /PRNewswire-FirstCall/ -- Cemtrex, Inc. (OTC: CTEX) announced that it has received Performance Test Protocol approval from NYDEC for its laser-based Continuous Opacity Monitoring system at a major medical center in Brooklyn, NY. "Our EPA3 laser opacity monitor is being installed in the boiler exhaust duct inside the hospital building conforming to the new PS-1 regulations," said Mr. Aron Govil, President and CEO of Cemtrex. "After carefully examining the location, we determined the proper configuration that would comply with the new PS-1 regulations and get the NYDEC approval." This hospital is a landmark in the Brooklyn area and Cemtrex is installing the complete EPA reporting software package for the laser opacity monitor designed to monitor the particulate emissions from the boiler exhaust flue gases. Cemtrex provides turnkey services for carbon creation projects from abatement of greenhouse gases pursuant to the Kyoto Protocol. Cemtrex, through its MIP-Ducon division, is engaged in manufacturing and selling the most advanced and custom-engineered instruments for emission monitoring. The Company's products are sold to power plants, refineries, chemical plants, cement plants and other industries, including federal and state governmental agencies. Safe Harbor Statement This press release contains forward-looking statements. Actual results could differ materially from those projected in the forward-looking statements as a result of a number of risks and uncertainties. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. For further information please contact: Cemtrex, Inc. 19 Engineers Lane Farmingdale, NY 11735 URL: http://www.cemtrex.com Email: firstname.lastname@example.org (516) 816-1400 This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.
SOURCE Cemtrex, Inc.